Department of Health and Human Services Overhauls Drug Pricing Transparency and Healthcare Procurement Rules
The United States Department of Health and Human Services initiated sweeping regulatory reforms aimed at lowering prescription drug costs through international reference pricing models and expanding price transparency mandates for hospital networks and insurance providers.